Study confirms frequency of undetected responsiveness in severe brain injury

With surprising frequency, patients with severe brain injury can show clear signs of cognitive function on brain scans in response to requests to carry out complex mental work, even when they can’t move or speak.

Josh Gully ’83 and partners build investment firm for ultra-wealthy

The newest episode of “Startup Cornell,” a podcast hosted by Entrepreneurship at Cornell, features Josh Gully ’83, managing director of NewEdge Wealth.

Around Cornell

David Reiss joins Cornell Law School and Cornell Tech faculties

On July 1, Cornell Law School and Cornell Tech welcomed David Reiss to their faculties as clinical professor of law and research director of the Blassberg-Rice Center for Entrepreneurship Law.

Around Cornell

General anesthetic may lead to new epilepsy treatments

Propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a new study.

Medicaid enrollees struggle to find psychiatric care

Many people enrolled in Medicaid who require psychiatric care have difficulty accessing clinicians in a timely manner despite the higher need in this population, according to a study by researchers at Weill Cornell Medicine.

Medicaid policies increase diversity in cancer clinical trials

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania and Medidata AI.

Blood test may guide use of multiple myeloma immunotherapy

A simple blood test that measures the number of lymphocytes may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy.

Model offers insights into Parkinson’s disease process

A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.

NIH grant awarded to investigate how immune system can banish HIV

Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.